(19)
(11)
EP 1 438 043 A2
(12)
(88)
Date of publication A3:
24.12.2003
(43)
Date of publication:
21.07.2004
Bulletin 2004/30
(21)
Application number:
02790295.6
(22)
Date of filing:
17.10.2002
(51)
International Patent Classification (IPC)
7
:
A61K
31/403
,
A61P
1/18
,
A61P
3/10
,
A61P
5/50
,
A61K
38/55
,
A61K
31/00
(86)
International application number:
PCT/EP2002/011636
(87)
International publication number:
WO 2003/032963
(
24.04.2003
Gazette 2003/17)
(84)
Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
Designated Extension States:
AL LT LV MK RO SI
(30)
Priority:
17.10.2001
US 344495 P
(71)
Applicant:
Aventis Pharma Deutschland GmbH
65929 Frankfurt am Main (DE)
(72)
Inventor:
YUSUF, Salim
Carlisle, Ontario L0R 1H2 (CA)
(54)
METHOD OF REDUCING TYPE 2 DIABETES IN HIGH RISK PATIENTS